Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover various ways to boost quick earnings that can enhance your income. Take action now and earn more!
20,595 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Mara Holdings and Riot Platforms fell Friday as higher energy costs collide with investors' questions about AI-driven...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
Millrose Properties marks its first year as an independent REIT with solid Q1 2026 earnings, expanding its builder ne...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
JPMorgan Chase CEO Jamie Dimon warns that markets may be riding an exuberant wave around AI and Big Tech, signaling ...
Zscaler is set to report Q3 after the close on May 28, 2026, with analysts eyeing ARR growth, AI monetization progres...
Arm Holdings has surged this year on AI infrastructure bets, but a breather may be near as the company shows solid ea...
Meta Platforms stock crushed the market today as Meta rolled out a business-focused AI tool worldwide. Investors weig...
Tech shares rebound as major indices claw back recent losses. Analysts say today’s tech rally beginning could extend ...